One of the most popular new drug classes in America—GLP-1 medications such as Ozempic, Wegovy, and Zepbound—has helped a reported 12 percent of Americans lose weight or manage their type 2 diabetes.
New data from the Journal of the American Medical Association shows an unusual rise in cases of a rare and potentially deadly brain disease in kids. The condition is usually triggered by the flu. NBC ...